300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Film
Oil and Gas
Retail
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Gibraltar
Burkina Faso
Africa
Singapore
Brazil
LATAM
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
China
Cameroon
Guernsey
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Turkey
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Ireland
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Spain
Albania
Argentina
Bangladesh
Barbados
Belgium
Europe
Jordan
Qatar
Ethiopia
Austria
Azerbaijan
Bulgaria
Angola
Cyprus
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Italy
Belize
Algeria
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Belarus
Finland
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Elev8.VC, VC Fund

Elev8.VC

VC Fund

Singapore, Singapore

Elev8.VC is a VC fund in Singapore focused on Health Care and Biotechnology. Elevate VC invest in and support early-stage deep tech founders (up to Series A), to scale their businesses globally.

Total investments:
27
Last investment:
Lead investor:
37%
Fund size:
$30M
Last fund:

Last updated:

Industries Elev8.VC invests in

Health CareBiotechnologyMedicalSoftwareInformation Technology

Stages Elev8.VC invests in

SeedSeries AFunding RoundPre-SeedVenture - Series Unknown

Countries Elev8.VC invests in

SingaporeUnited StatesGermanyIndonesia

Round sizes

Seed $1M–$4.8MSeries A $1.7M–$13M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$1M–$4.8M
Series A
$1.7M–$13M

Investment Focus

Industry

  • Health Care 4 (15%)
  • Biotechnology 4 (15%)
  • Medical 3 (11%)
  • Software 3 (11%)
  • Information Technology 3 (11%)
See all 40 industries →

Stage

  • Seed 13 (48%)
  • Series A 6 (22%)
  • Funding Round 2 (7%)
  • Pre-Seed 1 (4%)
  • Venture - Series Unknown 1 (4%)

Country

  • Singapore 13 (48%)
  • United States 3 (11%)
  • Germany 2 (7%)
  • Indonesia 1 (4%)

Team

NameTitleInvestmentsLinksEmail
Aditya Mathur
Aditya Mathur Founder & Managing Director
Founder & Managing Director Total investments: 6
Find email
Kendrick Loh Analyst
Analyst Total investments: 0
Find email
Remi Choong
Remi Choong Principal
Principal Total investments: 1
Find email

Investments

CompanyDescriptionRoundLinks
N&E Innovations is a med-tech company that develops antimicrobial products. $1.7M / Series A / Sep 09, 2026
2Strands Biosciences is a diagnostic company that aids cancer patient by developing blood-based monitoring tests. Pre-Seed / Mar 01, 2026
Polybee develops autonomous drone systems designed for agricultural applications. They focus on automating yield forecasting and pollination using drones, computer vision, and artificial intelligence. Their technology aims to reduce uncertainty in agriculture by providing solutions for seed companies, vertical farming operations, and greenhousecooperatives. Polybee's innovations are particularly useful in environments. $4.3M / Seed / Feb 09, 2026
Terra Oleo is a biotechnology company pioneering microbial technology to produce sustainable alternatives to palm oil derivatives and cocoa butter. $3.1M / Seed / Sep 17, 2025
Evitado focuses on automating airport operations by building an automation platform. This platform will provide algorithms for autonomous movement of all assets on the ground and insights for real-time decision-making in operations. Our first product is a portable LiDAR collision avoidance system to address the industry-wide pain point of aircraftground collision. This system is used during the movement of complex assets such as commercial aircraft and will be used as a foundation to build other functionalities for our airport automation platform. $3M / Venture - Series Unknown / Jul 24, 2025
FaradaIC Sensors is to commoditize gas sensors and provide flexible gas sensing at a cheap cost for the expanding market of IoT applications. $4.9M / Seed / Apr 07, 2025
Aevice Health provides non-invasive wearable technology that enables real-time monitoring of respiratory health. The devices facilitate early detection of cardiopulmonary issues and allow clinicians to track patient responses to treatment effectively. This approach enhances patient care by delivering critical insights directly from home. Jan 15, 2025
Auristone Providing actionable clinical insights with our epigenomics based workflows and actionable epigenomic information and analyses from proprietary pipelines and predictive models. $4M / Seed / Apr 02, 2024
Entropica Labs builds hardware-agnostic software infrastructure for fault-tolerant quantum computing. Their focus is the programmable layer that turns quantum processors into usable computers.Quantum systems must spend the overwhelming majority of their resources not on computation, but on quantum error correction (QEC): the continuous work ofdetecting and correcting the errors that would otherwise make results meaningless. Entropica's software sits above this layer, orchestrating the full fault-tolerant control loop and making it programmable across different qubit technologies. Founded in 2018 and headquartered in Singapore, Entropica works with quantum hardware partners across multiple qubit modalities to make fault-tolerant quantum computing practical, portable, and programmable. $4.7M / Series A / Nov 07, 2023
Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics. Mesh Bio works with healthcare providers and stakeholders to provide innovative solutions that transform health screening and disease management. They translate clinical data and numbers into actionable insights that help patientsbetter manage their health, lifestyle and disease risks. $3.5M / Series A / Oct 12, 2023
See all 27 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Film
Oil and Gas
Retail
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Gibraltar
Burkina Faso
Africa
Singapore
Brazil
LATAM
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
China
Cameroon
Guernsey
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Turkey
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Ireland
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Spain
Albania
Argentina
Bangladesh
Barbados
Belgium
Europe
Jordan
Qatar
Ethiopia
Austria
Azerbaijan
Bulgaria
Angola
Cyprus
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Italy
Belize
Algeria
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Belarus
Finland
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Elev8.VC invest in?

Elev8.VC invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Series A stage. Most of the 27 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Elev8.VC's check size?

Elev8.VC typically joins rounds of $1M–$4.8M at Seed and $1.7M–$13M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Elev8.VC participates in.

How do I contact Elev8.VC?

Public channels for Elev8.VC include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Elev8.VC?

The team at Elev8.VC includes Aditya Mathur (Founder & Managing Director), Kendrick Loh (Analyst) and Remi Choong (Principal). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Elev8.VC Elev8.VC Find emails